Rapid and life-threatening heart failure induced by pazopanib. (16th August 2018)

• Record Type: Journal Article
• Authors: Wang, Haotong; Rodriguez-Pla, Alicia; Campagna, Anthony
• Is Part Of: BMJ case reports. Volume 2018
• Publication Date: 2018-08-16
• Subjects: heart failure -- cancer intervention; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2018-225613
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : A 70-year-old man with history of stage IV renal cell carcinoma, chronic atrial fibrillation on warfarin, coronary artery disease status post-percutaneous coronary intervention resulting in an ischaemic cardiomyopathy with left ventricular ejection fraction of 40%–45%, presented with shortness of breath 10 days after starting pazopanib. Within the first week of starting pazopanib, the patient developed fatigue and progressive dyspnoea on exertion. His symptoms quickly worsened and he had compromised mental status. He was transferred to the intensive care unit (ICU) and intubated due to continued respiratory distress. He was found to be in cardiogenic shock and was started on inotropic support with dobutamine and norepinephrine. With maximum support, the patient was slowly weaned off vasopressors and was successfully extubated on ICU day 9. His hospital stay lasted 29 days with management of multiple medical complications, and he was eventually discharged to a rehabilitation facility.